Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001790340-24-000073
Filing Date
2024-10-02
Accepted
2024-10-02 16:11:03
Documents
13
Period of Report
2024-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A imrx-20240311.htm   iXBRL 8-K/A 21818
  Complete submission text file 0001790340-24-000073.txt   152570

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20240311.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20240311_lab.xml EX-101.LAB 23705
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20240311_pre.xml EX-101.PRE 13601
15 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20240311_htm.xml XML 2924
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40675 | Film No.: 241347406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)